4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-026742
CEO sold 7,806 shares at $21.18 ($165,331)
- CEO acquired 15,625 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2023-04-29 | Option exercise | +15,625 | 116,103 | D | ||
| DAVIS STEPHEN CEO | 2023-05-01 | Sale | −7,806 | $21.18 | $165,331 | 108,297 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2023-04-29 | Option exercise · Restricted Stock Units | −15,625 | 0 | D | ||
| Open-market sales · 7,806 sh · avg $21.18 · $165,331 | |||||||
Loading xslF345X04/doc4.xml…